Estée Lauder expands restructuring; cumulative approved charges $1.367B

This filing

Cumulative charges approved through March 31, 2026 $ 15 $ 3 $ 976 $ 373 $ 1,367

Comparable filing

Plan as well as savings related to certain restricted stock units lapsing over the next twelve months. The Company estimates that it will incur pre-tax charges in the range of $0.14 million to $0.20 million in connection with the Plan, consisting of approximately $0.10 to $0.15 in future cash-based expenditures associated with severance and benefit payments and

This filing

Cumulative charges approved through March 31, 2026 $ 15 $ 3 $ 976 $ 373 $ 1,367

Comparable filing

Item 2.05 Costs Associated with Exit or Disposal Activities. On April 29, 2026, Autolus Therapeutics plc (the “Company”) announced its Board of Directors approved a plan to improve operational efficiency and reduce operating expenses. This plan will implement a reduction in force whereby the Company will eliminate approximately 13% of the Company’s workforce, inclusive of employee-related actions that began in the second half of 2025. The Company anticipates that it will complete the implementation of the plan by the third quarter of 2026. Affected employees will be offered separation benefits, including severance payments and, where applicable, temporary healthcare coverage assistance. The Company estimates that it will incur total expenses relating to the realignment of approximately $8 million, consisting of severance and termination-related costs. The Company expects to record a significant portion of these charges in the first half of 2026.

This filing

Cumulative charges approved through March 31, 2026 $ 15 $ 3 $ 976 $ 373 $ 1,367

Comparable filing

Ahead of its name change to "People Incorporated" which is expected to occur with the release of Q2 2026 earnings in August, the Company has initiated a plan to consolidate its corporate functions with those of its People Inc. business (" People "), through a reduction in workforce, technology integrations, and other cost-saving measures over the coming quarters (the " Plan "). The Plan is expected to generate annual run-rate cost savings of approximately $40 million. The Plan is expected to be completed by Q1 of 2027. The Company expects to incur approximately $14 million in severance and related expenses, $48 million in non-cash stock-based compensation expense and $0.5 million to $1 million in other costs related to the Plan.

This filing

Cumulative charges approved through March 31, 2026 $ 15 $ 3 $ 976 $ 373 $ 1,367

Comparable filing

On April 9, 2026, the Company also announced a cost reduction program that includes a reduction in the Company’s workforce of approximately 11% of its full-time roles, including certain management roles and two executive roles. In connection with this workforce reduction, the Company expects to incur aggregate charges of approximately $8.5-$9 million, consisting primarily of employee-related costs, including severance, benefits, and other related expenses.

This filing

Cumulative charges approved through March 31, 2026 $ 15 $ 3 $ 976 $ 373 $ 1,367

Comparable filing

On April 2, 2026, the Company initiated a workforce reduction, which it expects to be completed by mid-year 2026, that will impact up to 5% of its employees. The reduction is part of a broader effort to optimize the Company’s cost structure. The Company expects to incur restructuring charges of approximately $0.2 million, primarily for severance and related costs, in the second quarter of 2026.

This filing

Cumulative charges approved through March 31, 2026 $ 15 $ 3 $ 976 $ 373 $ 1,367

Comparable filing

This organizational change plan will result in approximately 20% reduction in the global workforce, and together with cost-containment measures are expected to produce approximately $10 million of annualized cash savings. In connection with the workforce reduction, the Company expects to incur $0.6 million of termination costs in its second fiscal quarter and incur $0.7 million of costs in its third fiscal quarter ending June 30, 2026.

This filing

Cumulative charges approved through March 31, 2026 $ 15 $ 3 $ 976 $ 373 $ 1,367

Comparable filing

on March 19, 2026, the Company reduced the number of its employees in order to reduce cash expenditures and extend its operational runway. As a result, the Company expects to incur pre-tax cash charges of approximately $51,000 associated with severance payments to former employees.

This filing

Cumulative charges approved through March 31, 2026 $ 15 $ 3 $ 976 $ 373 $ 1,367

Comparable filing

On March 25, 2026, EnerSys announced a plan to close its facility in Tijuana, Mexico, which focused on manufacturing lead acid batteries. EnerSys expects to incur a pre-tax charge of approximately $37 million under this restructuring plan when completed, the majority of which is expected to be incurred by the second half of fiscal year 2027, of which $14 million is expected to be non-cash charges primarily from equipment write-offs. Cash charges of approximately $23 million, include severance and employee retention costs, environmental related expenses and equipment decommissioning, along with contractual releases and legal expenses.